Literature DB >> 28676993

Crystalline retinopathy association with flupentixol intake.

Pradeep Kumar1, Raghav Ravani2, Prateek Kakkar2, Anu Sharma2, Atul Kumar2.   

Abstract

AIM: To report the first case report of an association between flupentixol and crystalline retinopathy. STUDY
DESIGN: Observational, Case report. CASE REPORT: We report a case of crystalline retinopathy in a 36-year-old female who was suffering from depression and being treated with tablet flupentixol in a cumulative dose of 4380 mg over two years. Fundus examination of both eyes showed multiple, discrete, yellowish white refractile intraretinal deposits over the macula and peripapillary region, located in the inner retina as shown by OCT.
CONCLUSION: We propose regular retinal evaluation in patients with chronic flupentixol intake and larger studies to establish causal relationship between flupentixol and crystalline retinopathy.

Entities:  

Keywords:  Crystalline; Flupentixol; Retinopathy

Mesh:

Substances:

Year:  2017        PMID: 28676993     DOI: 10.1007/s10792-017-0624-1

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  10 in total

Review 1.  The differential diagnosis of crystals in the retina.

Authors:  F Nadim; H Walid; J Adib
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Autosomal dominant crystalline dystrophy.

Authors:  B W Richards; D E Brodstein; J J Nussbaum; J R Ferencz; K Maeda; L Weiss
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

3.  Crystalline retinopathy from nasal ingestion of methamphetamine.

Authors:  Radhika L Kumar; Peter K Kaiser; Michael S Lee
Journal:  Retina       Date:  2006-09       Impact factor: 4.256

4.  Canthaxanthin retinopathy. An investigation by light and electron microscopy and physicochemical analysis.

Authors:  B Daicker; K Schiedt; J J Adnet; P Bermond
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

5.  Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy.

Authors:  Stephanie Halford; Gerald Liew; Donna S Mackay; Panagiotis I Sergouniotis; Richard Holt; Suzanne Broadgate; Emanuela V Volpi; Louise Ocaka; Anthony G Robson; Graham E Holder; Anthony T Moore; Michel Michaelides; Andrew R Webster
Journal:  Ophthalmology       Date:  2014-01-28       Impact factor: 12.079

6.  Choroidal findings in Bietti's crystalline dystrophy.

Authors:  Jennyfer Zerbib; Raphaëlle Ores; Giuseppe Querques; Rislie Bouzitou-Mfoumou; Eric H Souied
Journal:  Retin Cases Brief Rep       Date:  2014

Review 7.  Crystalline retinopathies.

Authors:  Kimberly Drenser; David Sarraf; Atul Jain; Kent W Small
Journal:  Surv Ophthalmol       Date:  2006 Nov-Dec       Impact factor: 6.048

Review 8.  DETAILED CLINICAL PHENOTYPING OF OXALATE MACULOPATHY IN PRIMARY HYPEROXALURIA TYPE 1 AND REVIEW OF THE LITERATURE.

Authors:  Thierry Derveaux; Patricia Delbeke; Sophie Walraedt; Ann Raes; Steven Van Laecke; Bart P Leroy; Julie De Zaeytijd
Journal:  Retina       Date:  2016-11       Impact factor: 4.256

9.  Calcium oxalate retinopathy associated with methoxyflurane abuse.

Authors:  M A Novak; A S Roth; M R Levine
Journal:  Retina       Date:  1988       Impact factor: 4.256

10.  Tamoxifen retinopathy.

Authors:  C A McKeown; M Swartz; J Blom; J M Maggiano
Journal:  Br J Ophthalmol       Date:  1981-03       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.